Matt Damon is one of Hollywood’s most respected actors and a talent that every top director clamors to work with. Damon is the recipient of multiple awards and accolades, and after more than three ...
German pharma Bayer is moving into cell therapy R&D with its latest pact focusing on tough-to-treat lung cancers with Atara Biotherapeutics. Bayer has been moving deeply into gene therapies over the ...
Cell therapy developer Autolus has a lead program under FDA review for a type of blood cancer and in clinical development for other indications. As the company looks ahead to a potential product ...
Novartis aims to overcome two hurdles facing current cancer cell therapies: the lengthy time it takes to manufacture these personalized treatments and their inability to address solid tumors. The ...
What can a therapist using a psychobiological approach to couples therapy help with? Psychobiological approach to couples therapy (PACT) was originally developed to treat couples in severe distress, ...
On Monday, Sangamo Therapeutics, Inc. (NASDAQ:SGMO) regained the development and commercialization rights to giroctocogene fitelparvovec, an investigational gene therapy product candidate for ...
Prime Medicine received $110 million upfront and is eligible for over $3.5 billion in milestone payments. Clinical trial data for PM359, targeting CGD, is expected in 2025, with other programs ...
Correlation of molecular and clinically distinct phenotypes in HER2-overexpressing breast cancer (HER2+ BC) with estrogen receptor status (ER) status: Implications for anti-HER2 therapy. Background: ...
Gene therapy pioneer Jim Wilson and the University of Pennsylvania are teaming up with Regeneron to help deliver its COVID-19 antibody cocktail using adeno-associated virus (AAV) tech in the hope of ...
Takeda's pipeline has taken a hit as the company reported a safety signal from a midstage narcolepsy program. The Japanese pharma doubled down on gene therapy with a licensing deal with Selecta ...
Gilead Sciences (NASDAQ:GILD) on Wednesday announced a collaboration with the Swiss non-profit The Global Fund to accelerate access to lenacapavir, its newly approved HIV PrEP therapy, for people ...
Qualifications: BSc. Psych; GradDip. Psych, Master of Counselling, PACFA. Treatment modalities utilised: Cognitive Behaviour Therapy (CBT), Acceptance & Commitment Therapy (ACT) and Dialectical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback